These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6121358)

  • 1. [Membrane stabilizing actions of befunolol and indenolol, new beta-adrenergic receptor blocking drugs (author's transl)].
    Sada H; Harada S; Kojima M; Ban T
    Kokyu To Junkan; 1981 Nov; 29(11):1231-7. PubMed ID: 6121358
    [No Abstract]   [Full Text] [Related]  

  • 2. Electrophysiologically determined quinidine-like actions of a beta-adrenergic blocking agent, 1-(7-indenyloxy)-3-isopropylaminopropane-2-ol hydrochloride (YB-2).
    Tatsuno H; Shigenobu K; Kasuya Y
    Arch Int Pharmacodyn Ther; 1976 Jun; 221(2):197-207. PubMed ID: 9035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative pharmacological studies on beta-adrenolytic agents. An analysis of quantitative activity (author's transl)].
    Zechel HJ
    Arzneimittelforschung; 1977; 27(5):991-9. PubMed ID: 18159
    [No Abstract]   [Full Text] [Related]  

  • 4. Proceedings: Beta-adrenergic blocking and antiarrhythmic activities of 1-(7-indenyloxy)-3-tert-butylaminopropane-2-OL hydrochloride (YB-11).
    Noguchi Y; Nakao K; Kato H; Takagi K
    Jpn J Pharmacol; 1974; 24(0):s:73. PubMed ID: 4151686
    [No Abstract]   [Full Text] [Related]  

  • 5. Some central effects of indenolol in experimental animals.
    Tariq M; Babhair SA; Ageel AM; Ginawi OT; Parmar NS
    Res Commun Chem Pathol Pharmacol; 1986 Nov; 54(2):201-9. PubMed ID: 2878478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacological studies on the new indene derivatives with beta-adrenergic blocking activity (author's transl)].
    Tachikawa S; Takenaka T
    Yakugaku Zasshi; 1973 Dec; 93(12):1573-80. PubMed ID: 4150240
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of indenolol (YB-2), a new beta-adrenergic blocking agent, and its dextro isomer on the central nervous system of mice and rabbits.
    Tachikawa S; Takenaka T; Maeno H
    Arch Int Pharmacodyn Ther; 1978 Jul; 234(1):74-87. PubMed ID: 30422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the antifibrillatory activity of fluorinated derivatives of indenolol and nadolol in isolated rabbit and rat hearts: comparison with propranolol.
    Almotrefi AA; Aboul-Enein HY; Premkumar LS
    Arch Int Pharmacodyn Ther; 1989; 301():122-30. PubMed ID: 2576192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of beta-adrenoceptor blockers on mitochondrial ATPase activity in guinea pig heart preparations.
    Almotrefi AA; Dzimiri N
    Eur J Pharmacol; 1992 May; 215(2-3):231-6. PubMed ID: 1356792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on local anaesthetic and antiarrhythmic actions of 1-isopropylamino-3-(4-indanoxy)-2-propanol HCI (USVC-6524), a new beta-adrenoceptor antagonist.
    Madan BR; Vyas DS
    Indian J Physiol Pharmacol; 1973; 17(3):227-34. PubMed ID: 4151008
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effects of beta receptor blocking agent, 1-(7-indenyloxy)-3-isopropylaminopropane-2-ol hydrochloride (YB-2) on the circulatory system during intubation for general anesthesia].
    Kim SY; Miyamoto K; Yoshikawa K
    Masui; 1975 Aug; 24(8):780-6. PubMed ID: 240954
    [No Abstract]   [Full Text] [Related]  

  • 12. Dose-response studies of indenolol, a beta adrenoceptor blocker.
    Okupa FE; Daneshmend TK; Shrosbree E; Roberts CJ
    Clin Pharmacol Ther; 1981 Apr; 29(4):434-9. PubMed ID: 6110504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacology of a new beta-adrenoceptor blocking agent, The 15219.
    Caputi AP; Marmo E; Saini RK
    Res Commun Chem Pathol Pharmacol; 1972 Jul; 4(1):25-35. PubMed ID: 4152996
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardiovascular beta-adrenergic receptor blocking activities of 1-(7-indenyloxy)-3-isopropyl-aminopropane-2-ol hydrochloride (YB-2) and its optical isomers.
    Kato H; Noguchi Y; Nakao K; Takagi K
    Jpn J Pharmacol; 1974 Apr; 24(2):261-70. PubMed ID: 4152803
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of various structurally related beta-adrenoceptor blocking agents on maximum upstroke velocity of action potential in guinea-pig papillary muscles.
    Sada H; Ban T
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Nov; 317(3):245-51. PubMed ID: 6119623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency-dependent block of nerve conduction by beta-adrenergic blocking agents.
    Sada H; Ban T
    Arch Int Pharmacodyn Ther; 1981 Nov; 254(1):134-44. PubMed ID: 6121535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute effect of indenolol on systemic arterial pressure and heart rate in the rat.
    Zuccari G; Falcone A; Turba C
    Pharmacol Res Commun; 1986 Feb; 18(2):137-47. PubMed ID: 2871567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anti-arrhythmic and beta-adrenoceptor blocking activities of vanilol (author's transl)].
    Pan XX; Xiao JG; Lu YZ; Liu TP
    Zhongguo Yao Li Xue Bao; 1981 Jun; 2(2):97-101. PubMed ID: 6121452
    [No Abstract]   [Full Text] [Related]  

  • 19. [The beta-adrenergic blocking and antiarrhythmic activities of metabolites of befunolol hydrochloride (author's transl)].
    Masumoto S; Inoue H; Maruyama Y
    Nihon Yakurigaku Zasshi; 1979 Jul; 75(5):517-25. PubMed ID: 44259
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of indenolol on blood pressure, lower limb blood flow, adrenergic reflexes, and plasma renin activity.
    Poggesi L; Masotti G; Boddi M; Neri Serneri GG
    Clin Pharmacol Ther; 1987 Mar; 41(3):344-50. PubMed ID: 2880689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.